Cite
HARVARD Citation
Teerlink, J. et al. (2020). Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials. European journal of heart failure. pp. 2160-2171. [Online].